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Abstract
We describe an intein based method to site-specifically conjugate Quantum Dots (QDs) to target
proteins  in vivo. This approach allows the covalent conjugation of any nanostructure and/or
nanodevice to any protein and thus the targeting of such material to any intracellular compartment
or signalling complex within the cells of the developing embryo. We genetically fused a pleckstrin-
homology (PH) domain with the N-terminus half of a split intein (IN). The C-terminus half (IC) of
the intein was conjugated to QDs in vitro. IC-QD's and RNA encoding PH-IN were microinjected
into Xenopus embryos. In vivo intein-splicing resulted in fully functional QD-PH conjugates that
could be monitored in real time within live embryos. Use of Near Infra Red (NIR)-emitting QDs
allowed monitoring of QD-conjugates within the embryo at depths where EGFP is undetectable
demonstrating the advantages of QD's for this type of experiment. In conclusion, we have
developed a novel in vivo methodology for the site-specific conjugation of QD's and other artificial
structures to target proteins in different intracellular compartments and signaling complexes.
Background
The ability to target proteins in vivo with nanostructures
and/or nanodevices is crucial both for understanding and
controlling their biological function. Quantum Dots
(QD's) serve as an ideal model nanostructure due to i)
their superior optical properties that permit visual confir-
mation of in vivo targeting and localization and ii) their
potential as a bio-imaging tool. In contrast to traditional
fluorophores, QD's act as robust, broadly tunable nanoe-
mitters that can be excited by a single light source, offer
extremely high fluorescence intensity, wide excitation
spectra, narrow and tunable emission spectra, large stokes
shift and resistance to photobleaching [1]. Moreover,
there is currently a limited number of FP's with emission
in the Near Infra-Red (NIR) region. Despite claims of
improved optical properties they are still far from optimal
in terms of brightness and photostability, in comparison
to NIR-QD's [2-4]. The NIR region of the spectrum (700-
950 nm) is ideal for imaging through tissues because light
scattering diminishes with increasing wavelength, and
hemoglobin electronic and water vibrational overtone
absorptions approach their minimum over this spectral
domain. Furthermore living tissue auto fluorescence also
reaches a minimum at this range and the fluorescent sig-
nal can, even in the case of organic fluorophores, be
detected in vivo at subnanomolar quantities and at depths
sufficient for experimental or clinical imaging [5]. The full
potential of QD's is yet to be realized however because of
limitations related to their relatively large size (typically
20-30 nm for biocompatible red-emitting QD's [1]), mul-
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tivalency and the inability to genetically encode them. The
first two issues have been resolved to a large extent with
the synthesis of new types of QD's with much smaller
hydrodynamic radii [6] and monovalent nanocrystals [7].
The third issue remains elusive and therefore addressed in
this work using a simple intein-based method that allows
the site-specific conjugation of QD's to any protein target
in vivo, effectively overcoming the requirement to geneti-
cally encode QD's for tagging target proteins. In addition,
this approach can be used to conjugate other nanostruc-
tures or nanodevices to target proteins and as a result to
any intracellular compartment or protein signalling com-
plex within the cell
Existing methods of QD-protein conjugation generally
use either random chemical coupling with reactive
amino-acids (e.g. -NH2, -COOH, -SH) on the protein sur-
face or non-covalent complexation mediated by electro-
static interactions and ligand-recognition. A survey of site-
specific bioconjugation methods led us to the intein-
mediated ligation system. Inteins are polypeptide
sequences that are able to self-excise, rejoining the two
flanking extein sequences by a native peptide bond [8-10].
Inteins catalyze the splicing reaction through formation of
an active thioester intermediate and have been widely
used for in vitro protein semi-synthesis [9], segmental iso-
topic labelling [11] and in vivo protein cyclization [12].
This is the first time however that this approach has been
used successfully in a vertebrate embryo to label proteins
with QD's.
We selected to tag the PH domains of two proteins Akt
and Btk. These were chosen due to their ability to translo-
cate to the cell membrane upon PIP3 production by PI3-K
[13] and would thus provide a clear visual confirmation
of the conjugation in the intact embryo. Briefly, we genet-
ically tagged EGFP fusions of the PH domains of Akt and
Btk with the N-terminus half of a split intein (IN). The
complementary C-terminus half of the intein (IC) was
biotinylated and conjugated in vitro to streptavidin-coated
QD's. The RNA's encoding Akt-PH-IN or Btk-PH-IN were
delivered into Xenopus embryos via microinjection
together with the IC-QD's. In vivo association of the intein
halves in the cytosol triggered protein trans-splicing,
resulting in the ligation of the QD to the target protein
through a peptide bond (see Figure 1a).
We show in situ labeling of the PH domains of Akt and
Btk with QD's using the above described intein-mediated
ligation system. More specifically, we show that localiza-
tion of the PH-QD conjugates can be monitored in real
time in the developing Xenopus embryo. In addition we
show that the QD tag does not affect the primary function
of PH domains which is to recognize PIP3, as the ability to
translocate from the cytosol to the plasma membrane is
not compromised. Finally we show that in situ labeling of
proteins with QDs offers significant advantages over labe-
ling with traditional fluorophores and organic dyes.
Materials and methods
Embryos and explants
Xenopus laevis embryos from induced spawning [14] were
staged according to Nieuwkoop and Faber (1967). Oper-
ation techniques and buffer (MMR, Ubbels, 1983) have
been described [14]. Xenopus embryos were fertilized in
vitro and dejellied using 2% cysteine-HCl, pH 7.8, then
maintained in 0.1 × Marcc's Modified Ringer's (0.1 ×
MMR). Microinjections were performed in 4% Ficoll in
0.33 × MMR. The embryos were injected with RNA and
Intein (IC) peptide-QD conjugates at the 2 and 4-cell stage
according to established protocols [15]. After injections
the embryos were cultured in 4% Ficoll in 0.33 × MMR
until stage 8 and then cultured in either 0.1 × MMR or 400
nM Wortmannin (for some experiments) at room temper-
ature. For in vivo assays, the embryos were transferred to
slides for time lapse movies using Zeiss Axiocam MR3 and
the Axiovision software 4.6 to monitor GFP-QD co-local-
ization. For biochemical assays embryos were lysed and
loaded onto agarose gels.
Chemical Synthesis of biotinylated Intein (IC) peptide (IC-
Biotin)
H-MVKVIGRRSLGVQRIFDIGLPQDHNFLLAN-
GAIAANCFDYKDDDDK(Ahx-Biotin)G-NH2 Modifica-
tions: Biotin conjugated to lysine via a Ahx linker (6
carbon inert linker) A 47 amino acid peptide correspond-
ing to C-terminal intein (IC) was synthesized on a 0.5
mmol scale on a 4-methylbenzhydrylamine (MBHA)
resin according to the in-situ neutralization/HBTU activa-
tion protocol for Boc SPPS [16]. In order to put a biotin at
C-terminus, it was necessary to add an extra amino acid,
Lys, at the C-terminus. This Lys serves as a linking point
for biotin as well as a spacer between the peptide and
biotin. The peptide contains a cysteine protected with the
NPyS group which was added as the last amino acid in the
synthesis. Following chain assembly, global de-protection
and cleavage from the support was achieved by treatment
with HF containing 4% v/v pcresol, for 1 hour at 0°C. Fol-
lowing removal of the HF, the crude peptide product was
precipitated and washed with anhydrous cold Et2O
before being dissolved in aqueous acetonitrile (50% B)
and lyophilized. The crude peptide was purified by pre-
parative HPLC using a linear gradient of 25-45% B over 60
minutes. The purified peptide was characterized as the
desired product by ESMS. The lyophilized peptide was
dissolved in 60% DMSO at a concentration of 1 mg/ml.
In vitro conjugation of IC-Biotin to streptavidin-coated 
QDs
IC-Biotin was diluted to 50 μM and used at 1:1 volume
ratio with streptavidin-coated QDs (1 μM) (from Invitro-
gen or eBiosciences). To allow formation of the biotin-Journal of Nanobiotechnology 2009, 7:9 http://www.jnanobiotechnology.com/content/7/1/9
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In vivo conjugation of QD's to Akt-PH-EGFP via intein mediated protein splicing Figure 1
In vivo conjugation of QD's to Akt-PH-EGFP via intein mediated protein splicing. (a) Schematic representation of 
site-specific intein-mediated conjugation of QD's to target protein. (b) Co-localization of QDot585 with Akt-PH-EGFP on the 
cell membrane. Fluorescence images of stage 10 Xenopus embryos microinjected with the probe (IC-QDot585) shown in red, in 
one blastomere at the two-cell stage, and then injected with RNA encoding the target protein (Akt PH-EGFP-IN) shown in 
green, in three of four blastomeres. Yellow shows the overlap between red QDot585 and green EGFP indicating successful QD-
protein conjugation in a live embryo. (c) Biochemical characterization of protein-QD conjugates. Xenopus embryos were 
injected with either probe (Ic-QD's) only or Btk-PH-EGFP-IN RNA only or both, lysed at stage 10 and loaded onto a 0.5% aga-
rose gel. QDot655 were visualized with a band pass 650/30 emission filter under UV excitation and GFP was imaged with a band 
pass 500/50 filter set on UVP iBox Imaging System. The ligation product appears as a smeary band under both the GFP and QD 
filters, only in lysates of Xenopus embryos injected with both the RNA and the probe, and is denoted as Btk-PH-EGFP-QD 
conjugate. A single band corresponding to the Btk-PH-EGFP protein fusion that is not conjugated to QD's is also detectable 
under the GFP filter, in lysates of Xenopus embryos injected with RNA only or RNA and probe, but not QD's only.Journal of Nanobiotechnology 2009, 7:9 http://www.jnanobiotechnology.com/content/7/1/9
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streptavidin bond we incubate at 24°C for 30 min. To
remove any excess unbound peptide the conjugate was fil-
tered through microcon centrifugal filter units (YM100)
(Cat# 42413).
Analysis of QD-peptide conjugates
Analysis of QD-peptide conjugation was performed by
electrophoresis at 60 V for 4 h at 4°C using a 0.5% agarose
gel. No loading buffer was added to the samples before
loading. Gels were visualized under the ethidium bro-
mide filter (515-570 nm) with a UVP Imager (data not
shown).
Alternatively analysis of QD peptide conjugation was per-
formed by spotting nitrocellulose membranes (What-
man). Biotinylated IC peptide and IC peptide that did not
contain the biotin modification at the N-terminus were
spotted on nitrocellulose membrane and blocked in PBS
containing 1% BSA for 30 min at room temperature. The
nitrocellulose membrane was then soaked in PBS contain-
ing streptavidin-coated QDs (1:500 dilution) for 30 min
at room temperature. The membrane was washed with
PBS-Tween 20 (1%) twice and visualized under the ethid-
ium bromide filter (515-570 nm) with a UVP Imager
(data not shown).
Plasmids and Cloning
All plasmids were constructed using standard molecular
biology techniques and they were sequenced to verify cor-
rect coding.
pCS2++-Btk PH-EGFP-IN
A PCR fragment amplified with IGpr62 (TGTACAG-
GCGCGCGTACGGCGGCGGCGGCGGCGGC AAGTTT-
GCGGAATA TTGCCTCAG) and IGpr64 (CGCGCG GC
GGCCGCTTATTTAATTGTCCCAGCG) encoding IN with 5
N-terminal extein residues (KFAEY), using the pJJDuet30
plasmid (from Addgene) as template was inserted at the
C-terminus of Btk-PH-EGFP [13] on pEGFPN1 between
the BsrG I and Not I restriction sites. Btk-PH-EGFP-IN was
then inserted into the multiple cloning site of the pCS2++
plasmid by restriction enzyme digest with EcoR I-Not I
pCS2++-Akt PH-EGFP-IN
A PCR fragment amplified with Apr1 (AAGATCGATAT-
GAGCGACGTGGCTATTG) and Apr3 (AAGGAATTCCTT-
GTACAGCTCGTCCATGCCGAG) encoding Akt PH-EGFP,
using the pAkt PH-EGFP-N1 plasmid [13] as template,
was inserted into the multiple cloning site of the pCS2++
plasmid between the ClaI-EcoRI restriction sites. A PCR
fragment amplified with IGpr61 (AAGGAATTCAAGTTT-
GCGGAATATTGCCTCAGTTTTGG) and IGpr63 (AAGC
TCGAGTTATTTAATTGTCCCAGCG) encoding IN with 5
N-terminal extein residues (KFAEY), using the pJJDuet30
plasmid (from Addgene) as template was inserted at the
C-terminus of Akt PH-EGFP on pCS2++ between the
EcoRI-XhoI restriction sites.
All plasmids were transcribed into RNA using mMessage
mMachine Sp6 kit (Ambion) and the mRNAs were puri-
fied using the Mega Clear kit (Ambion). Microinjections
performed in Ficoll as mentioned above.
Electrophoretic analysis of protein trans-splicing
Biochemical analysis of protein-trans splicing was per-
formed by lysis of injected Xenopus embryos at stage 10.
Lysis was performed by pipetting up and down in the
presence of proteinase inhibitors (Sigma) and DNAse
(Roche). Lysates were then loaded onto agarose gels run at
100 V for 2 h, at 4°C. Gels were visualized with a UVP
Imager.
Results and Disussions
To demonstrate in situ labeling of the target protein with
QD's we injected both blastomeres of two-cell stage Xeno-
pus embryos with the probe (IC-QDot585), allowed the
embryo to develop to the four cell stage and then injected
three out of four blastomeres with RNA encoding the tar-
get protein (in this case, Akt PH-EGFP-IN). The presence of
EGFP on the PH domain allowed us to monitor and com-
pare the distribution of the QD's vs the Akt-PH. As shown
in Figure 1b, QD's translocated to the membrane in cells
derived from the blastomere injected with both IC-
QDot585 and RNA, where they colocalized with Akt-PH-
EGFP. On the other hand, in cells that do not express the
Akt-PH-EGFP-IN, QD's remained in the cytosol (see Figure
1b, third pane inset, at 20 × magnification). In addition
cells in which the Akt PH-EGFP remained cytosolic, the
QD conjugates also remained in the cytosol. To further
establish that QD's were successfully conjugated to Akt-
PH-EGFP in vivo we used a biochemical approach. Xeno-
pus embryos injected as described above were lysed when
they reached stage 10 and loaded onto an agarose gel.
QDot655 were visualized with a band pass 650/30 emis-
sion filter under UV excitation and GFP was imaged with
a band pass 500/50 filter set on UVP iBox Imaging System
http://www.uvp.com/ibox.html. As shown in Figure 1c a
single band of the expected molecular weight for the Btk-
PH GFP appeared in lysates of Xenopus embryos injected
with the RNA encoding the target protein (Btk PH-GFP-
IN). This band could not be detected in lysates of Xenopus
embryos injected with the probe (IC peptide conjugated
QD655) only. A higher MW smeary band corresponding to
the semi-synthetic product appeared only in lysates of
Xenopus embryos injected with both the RNA encoding
the target protein (Btk PH-GFP-IN) and the probe (IC pep-
tide conjugated QD655). Importantly, this new band over-
laps with the QD signal. The smeary appearance of the
band in the agarose gel is due to the fact that the size of
the protein-QD conjugates varies greatly as a result of theJournal of Nanobiotechnology 2009, 7:9 http://www.jnanobiotechnology.com/content/7/1/9
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multivalency of commercially available streptavidin-
coated QDs (4-10 streptavidin molecules (53 kD each)/
QD giving 16-40 biotin binding sites implying 16-40 con-
jugated PH-GFP protein molecules per QD) resulting in a
significant increase in size. In fact, the large size of some
of the protein-QD conjugates combined with their lack of
charge prevents them from migrating in the gels as they
can be detected in the gel wells.
Previous studies have reported that UVB irradiation
induces Akt activation and consequent translocation to
the plasma membrane via a PI-3K/PDK dependent path-
way as well as via Erks and p38 kinase through their
downstream kinase, mitogen and stress-activated protein
kinase Msk1 [17,18]. In agreement with these studies,
upon exposure to UV light both the Akt-PH-EGFP and the
QD conjugates translocated to the cell membrane within
minutes, suggesting UV induced activation of PI3-K (Fig-
ure 2a). Furthermore the translocation of Akt-PH-EGFP
and the QD conjugates to the plasma membrane was
completely eliminated by wortmannin, a PI3-K specific
inhibitor suggesting that the observed translocation is
PI3-K dependent (Figure 2b). Collectively the data in Fig-
ures 1 and 2 show that the QD's were a) successfully con-
jugated to Akt-PH-EGFP in vivo and b) the QD tag did not
affect the primary function of the PH domain, which is to
recognize PIP3 and translocate to the cell membrane.
We went on to compare the photostability of the QD-con-
jugates to that of EGFP. To test this we used the QDot525-
Streptavidin from Invitrogen which have emission spectra
that closely match those of EGFP and repeated the conju-
gation and injections as described above. It should be
noted that unlike the QDot585 Streptavidin conjugates
which fail to enter the nucleus, QDot525-Streptavidin have
sufficiently small hydrodynamic radii to do so. Injected
embryos were allowed to develop to stage 10 and were
then imaged on an epifluorescence microscope. Figure 3
shows that continuous exposure of the embryos to excita-
tion light (~ 480 nm) led to gradual loss of the EGFP sig-
nal, due to photobleaching, but did not affect the
QDot525-Streptavidin signal even after 20 minutes of con-
tinuous excitation. Importantly and despite the long
exposure to excitation light the QD conjugates retained
their membrane localization.
The possibility of taking advantage of the NIR region of
the spectrum, which is ideally suited for biological imag-
ing [19] was one of the reasons we developed this system.
We have recently shown that labelling of blastomeres with
NIR QD's enables visualization of deep tissue movements
with single cell resolution [20]. We postulated that NIR
QD labelling of a protein would enable the visualization
of protein localization in the living embryo beyond the
superficial cell layers. To achieve this we used streptavi-
din-coated NIR QD's (emission maxima centered at 800
nm). NIR QDot800 enabled the visualization of the Akt-
PH several cell layers deep where the GFP signal is either
undetectable or too diffuse to provide any meaningful
information (see Figure 4b).
Despite their ideal optical properties, commercially avail-
able CdSe/ZnSe QD's especially those emitting in the NIR
are large and can impair trafficking of proteins to which
they are attached and limit access to crowded cellular loca-
tions such as the cell membrane or even restrict access into
membrane bound intracellular compartments such as the
nucleus [7,20,21]. A large fraction of the QD size comes
from the passivating layer, often a polyacrylic acid poly-
mer or phospholipids micelle, required to allow conjuga-
tion of biological molecules to QD's and retention of their
optical properties [1]. We used commercially available
QD's from Invitrogen and eBiosciences (15-20 nm in
diameter), that did not only have the passivating layer but
were further coupled to streptavidin, as described earlier.
Conjugates of Akt-PH with QD's from all the emission
wavelengths tested (525, 565, 585, 605, 705, 800) could
translocate to the cell membrane, However, there was a
definitive size dependence in their ability to do so, with
longer wavelength emitting QD's showing a diminished
capacity to do so (compare Figure 3 (QDot525) to Figures
1b (QDot585) and Figure 4a (QDot705). In addition and in
agreement with previously published work [20], only pro-
tein conjugates with QDot525  (from Invitrogen) and
QD605 (from eBiosciences), were able to translocate into
the nucleus, as efficiently as an organic fluorophore con-
jugate (Cy3) (compare Figure 3 to Figure 1b (QDot585),
Figure 4a (QDot705) and Figure 2b (QDot655) and data
not shown). Longer wavelength protein-QD conjugates
were completely excluded from this membrane bound
intracellular compartment. The fact that QD's605 from eBi-
osciences but not from Invitrogen entered the nucleus
could be a result of different coating of the QD's or lower
number of streptavidin molecules per nanocrystal. Our
present results point to the need for wider availability and
commercialization of significantly smaller water soluble
nanocrystals with a variety of core and shell compositions
as synthesized by different groups [6,22-24].
Conclusion
Herein, we describe a simple and effective method that
enables the site-specific conjugation of QD's and other
artificial structures to target proteins in vivo. QD's were
chosen as a model nanostructure due to their superior
optical properties that facilitate detection and enable eval-
uation of the conjugation method. Site-specific conjuga-
tion of QD's to proteins was afforded by intein-based
protein trans-splicing. Unlike other conjugation methods,
the intein method is a traceless ligation, that is the intein
itself is spliced out and excluded from the final conjuga-Journal of Nanobiotechnology 2009, 7:9 http://www.jnanobiotechnology.com/content/7/1/9
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UV-inducible and wortmannin-sensitive translocation of QD-Akt-PH-EGFP conjugates to the membrane Figure 2
UV-inducible and wortmannin-sensitive translocation of QD-Akt-PH-EGFP conjugates to the membrane. (a) 
Akt-PH-EGFP protein fusions and Akt-PH-QDot585 conjugates translocate to the cell membrane upon exposure of injected 
Xenopus embryos to UV radiation. Live Xenopus embryos injected as described were imaged on a Zeiss Axioimager to visual-
ize the localization of Akt-PH-EGFP and Akt-PH-QD conjugate before and after exposure to UV radiation for 5 min. Both Akt-
PH-EGFP and Akt-PH-QD conjugates translocate to the cell membrane following brief exposure to UV radiation. (b) Translo-
cation of Akt-PH-QD conjugates (QDot655) to the cell membrane is Wortmanin sensitive. Live Xenopus embryos were imaged 
on a Zeiss Axioimager to visualize the localization of Akt-PH-QD conjugate before and after treatment with Wortmannin (400 
nM), a PI3-K inhibitor, for 1 hour. The Akt-PH QD conjugates become diffusely localized in the cytosol after treatemnt.Journal of Nanobiotechnology 2009, 7:9 http://www.jnanobiotechnology.com/content/7/1/9
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QD-Akt-PH conjugates are resistant to photobleaching, unlike Akt-PH-EGFP fusions Figure 3
QD-Akt-PH conjugates are resistant to photobleaching, unlike Akt-PH-EGFP fusions. Fluorescence images of 
stage 10 Xenopus embryos microinjected with the probe (IC-QD525) and with RNA encoding the target protein (Akt PH-
EGFP-IN), both shown in green since their emission spectra are closely matched. Embryos were exposed to continuous excita-
tion (~ 480 nm) for > 20 min. This led to gradual loss of the EGFP signal but did not affect the QDot525 signal.Journal of Nanobiotechnology 2009, 7:9 http://www.jnanobiotechnology.com/content/7/1/9
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tion product. In addition to site-specificity, intein-based
protein trans splicing has several other advantages,
including high efficiency of product formation, reproduc-
ibility and versatility as it allows the targeting of any nan-
oparticle (QD or other) to a protein of interest.
An important feature of this conjugation method is the
fact that target protein functionality is not affected upon
fusion with QD's. In fact QD-PH conjugates retained full
functionality of the PH domain as indicated by their abil-
ity to i) recognize PIP3, and ii) to translocate to the cell
membrane in a PI3-K dependent manner (Figure 1b-d).
This should hold true for most proteins as the QD is fused
post-translationally to the target protein and does not
therefore influence protein folding and tertiary structure,
in contrast to fluorescent protein fusions.
In addition, conjugation of QD's to the PH domain did
not affect the ability of the former to resist photodegrada-
tion. Photostability is one of the main advantages of QD
detection as it allows prolonged visualization of the
labelled protein and thus facilitates determination of its
function as well as delineation of the pathway in which it
is involved. We found no loss of fluorescence intensity in
PH-QD conjugate injected embryos even after 20 min of
continuous illumination, whereas there was complete
loss of EGFP fluorescence after 5 min of illumination (Fig-
ure 2).
Moreover, this conjugation method is easily adaptable to
the needs of the individual experiment as it allows use of
different streptavidin-coated QD's (emitting at different
wavelengths) to observe the same target protein, without
having to change any other reagent in the experiment. For
instance, use of Near Infra Red (NIR)-emitting QDs
allowed monitoring of QD-conjugates within the embryo
at depths where EGFP is undetectable demonstrating the
advantages of NIR-QD's for this type of experiment.
However, our present results point to the need for wider
availability and commercialization of smaller water solu-
ble nanocrystals and controlled nanoparticle valency. The
combination of efficient and non-reversible fusion of
QD's to target proteins with reduced QD size and mono-
valency could help to make the strategy described in this
paper a standard tool for in vivo imaging of protein
dynamics at the single-molecule level. Finally, this meth-
odology could be invaluable due to its potential diagnos-
tic and therapeutic implications, as it makes the targeting
of nanostructures and nanodevices to different intracellu-
lar compartments and signaling complexes a viable possi-
bility.
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